Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prevalence of thyroid disorders in patients with immune thrombocytopenic purpura and its impact on treatment
We investigate patients with ITP for screening of thyroid disorders and how to deal with it and effect of this on the ttt
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients known ITP | Patients known ITP either newly diagnosed, chronic, refractory Age 18 yrs and above Patients with thyrodiectomy will not be in our study |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Search for thyroid disorders | Diagnostic Test | TSH , FT3 , FT4 |
|
| Measure | Description | Time Frame |
|---|---|---|
| Assess the frequency of thyroid disorders in patients with IT | Screening of thyroid disorders in patients with ITP | Assess the frequency of thyroid disorders in patients with IT |
| Evaluate the treatment of thyroid disorders in improvement in platelets count. | Evaluate if patients have managed according to thyroid disorders, will this affect in their response to ITP management | Evaluate the treatment of thyroid disorders in improvement in platelets count. |
Not provided
Not provided
Inclusion Criteria:
ITP patients will be classified as newly diagnosed, persistent and chronic based on duration less than 3 months, 3-12 months, and more than 12 months respectively.
Exclusion Criteria:
patients with history of thyroidectomy
Not provided
Not provided
Not provided
prospective cross sectional study
Not provided
| ID | Term |
|---|---|
| D016553 | Purpura, Thrombocytopenic, Idiopathic |
| D013959 | Thyroid Diseases |
| ID | Term |
|---|---|
| D011696 | Purpura, Thrombocytopenic |
| D011693 | Purpura |
| D001778 | Blood Coagulation Disorders |
| D006402 | Hematologic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019411 | Clinical Laboratory Techniques |
| D013256 | Steroids |
| D007293 | Inosine Triphosphate |
| ID | Term |
|---|---|
| D019937 | Diagnostic Techniques and Procedures |
| D003933 | Diagnosis |
| D008919 | Investigative Techniques |
| D000072473 | Fused-Ring Compounds |
Not provided
Not provided
Not provided
Not provided
Not provided
| Laboratory test | Diagnostic Test | Search for anti thyroid antibodies |
|
| Steroid and eltrombopage | Drug | See when we treat thyroid disorders, will patient respond to steroid or eltrombopage? |
|
|
| D006425 |
| Hemic and Lymphatic Diseases |
| D057049 | Thrombotic Microangiopathies |
| D013921 | Thrombocytopenia |
| D001791 | Blood Platelet Disorders |
| D000095542 | Cytopenia |
| D006474 | Hemorrhagic Disorders |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D006470 | Hemorrhage |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012877 | Skin Manifestations |
| D012816 | Signs and Symptoms |
| D004700 | Endocrine System Diseases |
| D011083 | Polycyclic Compounds |
| D007292 | Inosine Nucleotides |
| D011685 | Purine Nucleotides |
| D011687 | Purines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
| D009711 | Nucleotides |
| D009706 | Nucleic Acids, Nucleotides, and Nucleosides |
| D012265 | Ribonucleotides |